This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignee: E. R. Squibb Sons, Inc.. Active years: 1992-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Philadelphia, PA (US) (1993)
- Yardley, PA (US) (1992 - 2000)
Company Filing History:
Years Active: 1992-2000
Title: Veeraswamy Manne: Innovator in Cancer Research
Introduction
Veeraswamy Manne is a notable inventor based in Yardley, PA, who has made significant contributions to the field of cancer research. With a total of four patents to his name, he has focused on innovative methods to combat neoplastic transformations in cells.
Latest Patents
One of his latest patents is a method for blocking neoplastic transformation of cells induced by the ras oncogene. This method involves preventing the prenylation of CAAX box containing proteins, which includes administering a therapeutically effective amount of a protein-prenyl transferase inhibitor to prevent and treat ras-related tumors. Another significant patent is for the production of 10'-desmethoxystreptonigrin by Streptomyces albus. This compound, obtainable through the cultivation of a specific strain, exhibits antitumor and antibiotic activity, showcasing the potential for therapeutic applications.
Career Highlights
Veeraswamy Manne is associated with E.R. Squibb & Sons, Inc., where he has been able to apply his research and innovations in a corporate setting. His work has contributed to advancements in cancer treatment methodologies.
Collaborations
Throughout his career, Manne has collaborated with esteemed colleagues such as Mariano Barbacid and Edward Meyers, further enhancing the impact of his research in the scientific community.
Conclusion
Veeraswamy Manne's contributions to cancer research through his innovative patents highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in therapeutic strategies against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
